LNG-IUS may relieve heavy menses in women with hemostatic disorders

Article

LNG-IUS provides effective treatment for abnormal uterine bleeding and improves quality of life in women with von Willebrand's disease.

The levonorgestrel-releasing intrauterine system (LNG-IUS) provides effective treatment for abnormal uterine bleeding and improves quality of life in women with von Willebrand's disease and/or who are receiving anticoagulation therapy for a thrombotic disorder, according to the findings of a small retrospective case series study conducted at a North Carolina tertiary medical center.

Seven women with heavy menstrual bleeding and a median age of 38 years used the LNG-IUS and completed a survey. Four had von Willebrand's disease, three were taking warfarin, two were taking aspirin, and one had both von Willebrand's and was heterozygous for factor V Leiden.

The hormone-releasing system reduced the number of bleeding days in 5 of the 7 women (71%) by a mean of 6 days (from 9 to 3). One woman stopped using the system because she wanted to become pregnant, and two (29%) saw no benefit.

Lukes AS, Reardon B, Arepally G. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders. Fertil Steril. 2008;90:673-677.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Ousseny Zerbo, PhD, highlights benefits of influenza vaccination during pregnancy | Image Credit: divisionofresearch.kaiserpermanente.org.
Michael Ussher, PhD, highlights the benefits of vaping over smoking in pregnancy | Image Credit: sgul.ac.uk.
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Related Content
© 2025 MJH Life Sciences

All rights reserved.